medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2010, Número 2

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2010; 8 (2)


Tularemia. Una revisión

Vargas MF, Arena R, Baños SC, Valencia FC, Torres GE

Idioma: Español
Referencias bibliográficas: 41
Paginas: 110-116
Archivo PDF: 204.67 Kb.


RESUMEN

La tularemia es una enfermedad infecciosa clásicamente trasmitida por vector, de áreas geográficas circunscritas, provocada por Francisella tularensis, bacteria muy virulenta que provoca en el ser humano diversos síndromes clínicos definidos. La enfermedad tiene especial relevancia debido a su potencial como arma terrorista. El pronóstico está determinado por la variedad clínica y es curable con antibióticos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Vincent A et al. “Bacterial diseases”. En Bolognia J, Jorizzo J, Rapini R. Dermatology. 2a ed. Nueva York, Mosby Elsevier, 2003, 1098.

  2. Borchardt S, Ritger K, Dworkin M. “Categorization, priorization and surveillance of potencial bioterrorism agents”. Infect Dis Clin N Am 2006; 20: 213-225.

  3. Fan J, Kraft A, Henrichson K. “Current methods for the rapid diagnosis of bioterrorism-related infectious agents”. Pediatr Clin N Am 2006; 53: 817-842.

  4. Lupi O, Madkan V, Tyring S. “Tropical dermatology: Bacterial tropical diseases”. J Am Acad Dermatol 2006; 54: 559-578.

  5. Nigrovic L, Wingester S. “Tularemia”. Infect Dis Clin North Am 2008; 22: 489-504.

  6. Arenas R. “Tularemia. 1er. caso ulceroganglionar en México”. En Fernando Latapí. Sus contribuciones a la dermatología. 1ª ed. México, Editores de Textos Mexicanos. 2009, 110-116.

  7. Eliasson H, Broman T, Forsman M et al. “Tularemia: Current epidemiology and disease management”. Infect Dis Clin North Am 2006; 20: 289-311.

  8. Edlow J. “Preface: Tick borne diseases”. Infect Dis Clin North Am 2008; 22: xiii-xv.

  9. Greisman S, Honick R, Wagner H et al. “The role of endotoxin tolerance mechanism during infection”. J Clin Invest 1969; 48: 613-629.

  10. Parker R, Lister L, Bauer R et al. “Use of chloramphenicol (chloromycetin) in experimental and human tularemia”. J Am Med Assoc 1950; 143: 7-11.

  11. Koenig K, Kahn C, Schultz C. “Medical strategies to handle mass casualties from the use of biological weapons”. Clin Lab Med 2006; 26: 313-327.

  12. Kman N, Nelson R. “Infectious agents of bioterrorism: A review for emergency physicians”. Emerg Med Clin North Am 2008; 26: 517-547.

  13. Mattix M, Zeman D, Moeller R et al. “Clinical aspects of animal and zoonotic diseases of bioterrorism”. Clin Lab Med 2006; 26: 445-489.

  14. Varios autores. WHO Guidelines on Tularemia. NLM Classification: WC380, Ginebra, Suiza, 2007, 3-125.

  15. Perry B. “Biological weapons: An introduction for surgeons”. Surg Clin North Am 2006; 86: 649-663.

  16. Shimshony A. “Tularemia: A threat to animals and humans”. Infectious Disease News 2009; 22: 16.

  17. Masters E, Grygery C, Masters R. “STARI, or Masters disease: Lone star tick-vectored Lyme-like illness”. Infect Dis Clin North Am 2008; 22: 361- 376.

  18. Speil C, Mushtaq A, Adamski A et al. “Fever of unknown origin in the returning traveler”. Infect Dis Clin North Am 2007; 21: 1091-1113.

  19. Nicolasora N, Kaul D. “Infectious disease emergencies”. Med Clin North Am 2008; 92: 427-441.

  20. Rabinowitz P, Gordon Z, Odofin L. “Pet-related infections”. Am Fam Physician. 2007; 76: 1314-1322.

  21. Cleri D, Ricketti A, Varnaleo J. “Fever of unknown origin due to zoonoses”. Infect Dis Clin North Am 2007; 21: 963-996.

  22. Anderson J, Magnarelli L. “Biology of ticks”. Infect Dis Clin North Am 2008; 22: 195-215.

  23. Moran G, Talan D, Abrahamian F. “Biological terrorism”. Infect Dis Clin North Am 2008; 22: 145-187.

  24. Luke A, d’Hemecourt P. “Prevention of infectious diseases in athletes”. Clin Sports Med 2007; 26: 321-344.

  25. Lester J, Christos S, Kordick M et al. “Terrorism: Can emergency medicine physicians identify terrorism syndromes?” Am J Emerg Med 2007; 25: 1019-1024.

  26. Stocker T. “Clinical and pathologic differential diagnosis of selected potential bioterrorism agents of interest to pediatric health care providers”. Clin Lab Med 2006; 26: 329-344.

  27. Morse S, Budowle B. “Microbial forensics: Application to bioterrorism preparedness and response”. Infec Dis Clin North Am 2006; 20: 455-473.

  28. Marty A. “Anatomic laboratory and forensic aspects of biological threat agents”. Clin Lab Med 2006; 26: 515-540.

  29. Van de Beek D, Steckelberg J, Marshall W et al. “Tularemia with brain abscesses”. Neurology 2007; 68: 531.

  30. Peker E, Ayaydin A, Duran N. “Familial tularemia”. Indian J Med Microbiol 2007; 27: 272-275.

  31. Hurt C, Tammaro D. “Diagnostic evaluation of mononucleosis-like illnesses”. Am J Med 2007; 120: 911.e1-8.

  32. Splettstoesser W, Tomaso H, Al Dahouk S et al. “Diagnostic procedures in tularaemia with special focus on molecular and immunological techniques”. J Vet Med B 2005; 52: 249-261.

  33. Eliasson H, Sjostedt A, Back E. “Clinical use of a diagnostic PCR for Francisella tularensis in patients with suspected ulceroglandular tularaemia”. Scan J Infect Dis 2005; 37: 833-837.

  34. 34- Higgins J, Hubalek Z, Halouzka J et al. “Detection of Francisella tularensis in infected mammals and vectors using a probe-based polymerase chain reaction”. Am J Trop Med Hyg 2000; 62: 310-318.

  35. Johansson A, Ibrahim A, Goransson I et al. “Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis”. J Clin Microbiol 2000; 38(11): 4180-4185.

  36. Berdal BP, Mehl R, Haaheim H et al. “Field detection of Francisella tularensis”. Scand J Infect Dis 2000; 32(3): 287-291.

  37. Fujita O, Tatsumi M, Tanabayashi K. “Development of a real time PCR assay for detection and quantification of Francisella tularensis”. Jpn J Infect Dis 2006; 59: 46-51.

  38. Tarnvik A, Chu M. “New approaches to diagnosis and therapy of tularemia”. Ann NY Acad Sci 2007; 1105: 378-404.

  39. Fuller C, Brittingham K, Hepburn M et al. “Letters to editor: Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination”. J Allergy Clin Immunol 2006; 117(5): 1186- 1188.

  40. Avashia S, Petersen J, Lindley C. “First reported prairie dog-to human tularemia transmission, Texas, 2002”. Emerg Infect Dis 2004; 10: 483- 486.

  41. Theiler R, Rasmussen S, Treadwell T et al. “Emerging and zoonotic infections in women”. Infect Dis Clin North Am 2008; 22: 755-772.




2020     |     www.medigraphic.com